CRSP · Insider trading · 13F holders · Congress trades
CRISPR Therapeutics AG (CRSP)
Who is buying and selling CRSP: company insiders on SEC Form 4, hedge funds and superinvestors on Form 13F, and members of Congress under the STOCK Act. Every figure links to the filing or page it comes from.
- 13F filers holding
- 27
- Insider buys, 90 days
- $0
- Insider sales, 90 days
- $4.9M
- Congress trades, 12 months
- 5
CRSP at a glance
- Between Aug 1, 2026 and Oct 29, 2026, 4 CRSP insiders filed 7 sales worth $4.9M on SEC Form 4, and no open-market purchases; 3 of the sales were pre-planned under Rule 10b5-1.
- 27 13F filers hold CRSP among their 50 largest positions, worth $1.4B combined, including Oleg Nodelman and Cathie Wood. The biggest bets by portfolio weight are GSK plc (29.2%), SR One Capital Management, LP (10.7%) and Oleg Nodelman (3.8%). In their latest 13Fs, 0 managers opened a new position and 2 added to one.
- Members of Congress have disclosed 7 CRSP trades since 2017, 2 purchases and 3 sales in the past year; the latest was Thomas R. Suozzi (D-NY), selling $50K–100K on Sep 20, 2021.
- CRSP last closed at $54.26 on Oct 29, 2026.
CRSP insider trading
Between Aug 1, 2026 and Oct 29, 2026, 4 CRSP insiders filed 7 sales worth $4.9M on SEC Form 4, and no open-market purchases; 3 of the sales were pre-planned under Rule 10b5-1.
| Filed | Insider | Role | Trade | Shares | Price | Value | Form 4 |
|---|---|---|---|---|---|---|---|
| Oct 20, 2026 | Kulkarni Samarth | Chief Executive Officer, Director | Sale | 47,837 | $49.78 | $2.4M | SEC |
| Oct 16, 2026 | George Simeon | Director | Sale10b5-1 | 14,514 | $49.63 | $720K | SEC |
| Oct 15, 2026 | Kulkarni Samarth | Chief Executive Officer, Director | Sale | 4,098 | $49.26 | $202K | SEC |
| Oct 15, 2026 | Kasinger James R. | General Counsel and Secretary | Sale | 1,040 | $49.26 | $51K | SEC |
| Oct 8, 2026 | Kasinger James R. | General Counsel and Secretary | Sale10b5-1 | 1,990 | $60.04 | $119K | SEC |
| Sep 24, 2026 | Kasinger James R. | General Counsel and Secretary | Sale10b5-1 | 10,400 | $60.24 | $626K | SEC |
| Sep 21, 2026 | Behbahani Ali | Director | Sale | 13,679 | $57.09 | $781K | SEC |
Who owns CRSP? Hedge funds and superinvestors
27 13F filers hold CRSP among their 50 largest positions, worth $1.4B combined, including Oleg Nodelman and Cathie Wood. The biggest bets by portfolio weight are GSK plc (29.2%), SR One Capital Management, LP (10.7%) and Oleg Nodelman (3.8%). In their latest 13Fs, 0 managers opened a new position and 2 added to one.
Superinvestors holding CRSP: Oleg Nodelman 3.8% · Cathie Wood 3.4%
| Manager | % of portfolio | Value | Shares | Last quarter | 13F |
|---|---|---|---|---|---|
| Cathie WoodMutual fund manager | 3.4% | $516.0M | 9,460,939 | -16.4% shares | Q2 2026 |
| Orbis Allan Gray LtdInvestment manager | 1.0% | $297.2M | 5,449,161 | -10.8% shares | Q2 2026 |
| GSK plcCorporation | 29.2% | $175.7M | 3,220,627 | +0.0% shares | Q2 2026 |
| SR One Capital Management, LPHedge fund | 10.7% | $111.2M | 2,038,763 | +0.0% shares | Q2 2026 |
| Amova Asset Management Americas, Inc.Hedge fund | 1.2% | $93.8M | 1,720,097 | -7.2% shares | Q2 2026 |
| Oleg NodelmanHedge fund | 3.8% | $75.8M | 1,389,276 | +0.0% shares | Q2 2026 |
| NEA Management Company, LLCHedge fund | 3.6% | $57.7M | 1,058,570 | +0.0% shares | Q2 2026 |
| IQ EQ FUND MANAGEMENT (IRELAND) LtdHedge fund | 1.3% | $20.8M | 381,991 | -4.7% shares | Q2 2026 |
| Logos Global Management LPHedge fund | 0.7% | $16.4M | 300,000 | — | Q2 2026 |
| Versant Venture Management, LLCVenture capital | 5.0% | $8.1M | 148,831 | +0.0% shares | Q2 2026 |
| Campbell & CO Investment Adviser LLCHedge fund | 0.3% | $5.9M | 107,529 | — | Q2 2026 |
| Clough Capital Partners L PHedge fund | 0.4% | $5.4M | 98,337 | — | Q2 2026 |
| Himension Capital (singapore) Pte. Ltd.Asset manager | 0.3% | $4.6M | 83,897 | -9.3% shares | Q2 2026 |
| Shah Wealth Advisors, LLCWealth manager | 0.9% | $3.8M | 69,060 | — | Q2 2026 |
| Green Alpha Advisors, LLCWealth manager | 2.1% | $3.1M | 56,786 | +1.8% shares | Q3 2026 |
| Privium Fund Management B.V.Asset manager | 0.5% | $2.5M | 44,974 | +4.9% shares | Q2 2026 |
| Palo Alto Investors LPHedge fund | 0.3% | $2.2M | 39,605 | +0.0% shares | Q2 2026 |
| Canal Insurance COInsurance company | 0.5% | $1.9M | 35,100 | — | Q3 2026 |
| Encore Global Management, LPHedge fund | 1.6% | $1.7M | 30,557 | — | Q2 2026 |
| Deuterium Capital Management, LLCHedge fund | 1.5% | $1.4M | 25,000 | +0.0% shares | Q2 2026 |
| Hedges Asset Management LLCWealth manager | 0.9% | $1.4M | 24,425 | -0.6% shares | Q3 2026 |
| Nano Cap New Millennium Growth Fund L PAsset manager | 0.9% | $1.1M | 20,500 | +0.0% shares | Q2 2026 |
| Farrow Financial, Inc.Wealth manager | 0.6% | $1.1M | 19,643 | +15.7% shares | Q2 2026 |
| Abu Dhabi Investment Council Co P.J.S.CSovereign wealth fund | 0.1% | $1.0M | 18,958 | +0.0% shares | Q2 2026 |
| Kassira Wealth Management LLCWealth manager | 0.7% | $876K | 15,839 | +0.0% shares | Q3 2026 |
| Norris Financial Group, LLCWealth manager | 0.2% | $494K | 9,061 | — | Q2 2026 |
| Elkhorn Partners Limited PartnershipHedge fund | 0.1% | $109K | 2,000 | +5.3% shares | Q2 2026 |
Each manager counts with its latest 13F (Q3 2026: 4, Q2 2026: 23). Screen CRSP in the grand portfolio →
CRSP stock trades by members of Congress
Members of Congress have disclosed 7 CRSP trades since 2017, 2 purchases and 3 sales in the past year; the latest was Thomas R. Suozzi (D-NY), selling $50K–100K on Sep 20, 2021.
| Filed | Member | Trade | Amount | Traded | Since |
|---|---|---|---|---|---|
| Oct 5, 2021 | Thomas R. SuozziD-NY · House | Sale | $50K–100K | Sep 20, 2021 | -55.8% |
| Sep 23, 2021 | Thomas R. SuozziD-NY · House | Buy | $50K–100K | Jun 3, 2021 | -53.1% |
| Feb 19, 2021 | Marjorie Taylor GreeneR-GA · House | Buy | $1K–15K | Jan 21, 2021 | -72.2% |
| Jan 15, 2021 | James M. InhofeR-OK · Senate | Sale | $1K–15K | Jan 5, 2021 | -67.5% |
| Dec 23, 2020 | James M. InhofeR-OK · Senate | Sale | $50K–100K | Dec 22, 2020 | -69.3% |
| Jun 20, 2018 | James M. InhofeR-OK · Senate | Sale | $15K–50K | Jun 19, 2018 | -16.0% |
| Nov 8, 2017 | James M. InhofeR-OK · Senate | Buy | $15K–50K | Oct 19, 2017 | +174.9% |
3 members have traded CRSP: Thomas R. Suozzi, Marjorie Taylor Greene, James M. Inhofe.
Analysis mentioning CRSP
Posts from the blog that cover CRISPR Therapeutics AG, newest first.
CRSP questions and answers
Are insiders buying CRSP stock?
Between Aug 1, 2026 and Oct 29, 2026, 4 CRSP insiders filed 7 sales worth $4.9M on SEC Form 4, and no open-market purchases; 3 of the sales were pre-planned under Rule 10b5-1.
Which hedge funds own CRSP?
27 13F filers hold CRSP among their 50 largest positions, worth $1.4B combined, including Oleg Nodelman and Cathie Wood. The biggest bets by portfolio weight are GSK plc (29.2%), SR One Capital Management, LP (10.7%) and Oleg Nodelman (3.8%). In their latest 13Fs, 0 managers opened a new position and 2 added to one.
Has Congress traded CRSP?
Members of Congress have disclosed 7 CRSP trades since 2017, 2 purchases and 3 sales in the past year; the latest was Thomas R. Suozzi (D-NY), selling $50K–100K on Sep 20, 2021.
Who is the largest holder of CRSP?
Among 13F filers, Cathie Wood reports the largest CRSP position, $516.0M (9,460,939 shares) in its Q2 2026 13F. The biggest bet by portfolio weight is GSK plc's: 29.2% of its portfolio.
Cite or share this
Free to use with a link back. The data updates every filing day.